Račkauskas, R., Zhou, D., Ūselis, S., Herr, I., & Schemmer, P. (2017). Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteins. Oncology reports, 37(6), . https://doi.org/10.3892/or.2017.5622
Chicago Style (17th ed.) CitationRačkauskas, Rokas, Dachen Zhou, Simonas Ūselis, Ingrid Herr, and Peter Schemmer. "Sulforaphane Sensitizes Human Cholangiocarcinoma to Cisplatin via the Downregulation of Anti-apoptotic Proteins." Oncology Reports 37, no. 6 (2017). https://doi.org/10.3892/or.2017.5622.
MLA (9th ed.) CitationRačkauskas, Rokas, et al. "Sulforaphane Sensitizes Human Cholangiocarcinoma to Cisplatin via the Downregulation of Anti-apoptotic Proteins." Oncology Reports, vol. 37, no. 6, 2017, https://doi.org/10.3892/or.2017.5622.